Cue Health, Inc.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US2297901009
USD
0.00
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'24
Dec'23
Sep'23
Jun'23
Mar'23
Dec'22
Sep'22
Net Sales
10.05
18.80
17.48
9.90
24.77
146.78
69.59
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
10.05
18.80
17.48
9.90
24.77
146.78
69.59
Raw Material Cost
16.32
35.74
22.18
29.35
39.82
90.78
50.59
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.15
0.34
0.30
0.29
0.22
0.23
0.35
Selling and Distribution Expenses
8.50
16.09
22.90
22.76
28.19
38.47
43.75
Other Expenses
2.91
3.19
3.68
3.62
4.45
5.59
4.22
Total Expenditure (Excl Depreciation)
54.09
84.08
82.18
88.64
112.74
185.40
136.87
Operating Profit (PBDIT) excl Other Income
-44
-65.3
-64.7
-78.7
-88
-38.6
-67.30000000000001
Other Income
0.81
0.88
1.83
1.82
1.87
2.04
0.41
Operating Profit (PBDIT)
-43.22
-49.19
-25.77
-62.25
-71.63
-22.92
-53.26
Interest
0.15
0.34
0.30
0.29
0.22
0.23
0.35
Exceptional Items
-6.14
-83.62
0.00
-6.64
-7.87
0.00
-0.14
Gross Profit (PBDT)
-6.26
-16.94
-4.70
-19.45
-15.06
55.99
18.99
Depreciation
0.00
15.22
16.16
14.68
14.48
13.66
13.60
Profit Before Tax
-49.52
-148.37
-42.24
-83.86
-94.20
-36.82
-67.35
Tax
0.00
0.06
4.73
0.00
0.00
-5.32
-1.05
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-49.52
-148.43
-46.97
-83.86
-94.20
-31.51
-66.30
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
-49.52
-148.43
-46.97
-83.86
-94.20
-31.51
-66.30
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
-49.52
-148.43
-46.97
-83.86
-94.20
-31.51
-66.30
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
199.46
250.25
388.83
423.18
495.86
576.49
589.96
Earnings per share (EPS)
-0.31
-0.96
-0.31
-0.55
-0.62
-0.21
-0.45
Diluted Earnings per share
-0.31
-0.96
-0.31
-0.55
-0.62
-0.21
-0.45
Operating Profit Margin (Excl OI)
-438.01%
-347.29%
-250.42%
-795.76%
-355.25%
-26.31%
-96.68%
Gross Profit Margin
-492.5%
-708.34%
-149.21%
-699.15%
-321.91%
-15.78%
-77.24%
PAT Margin
-492.5%
-789.62%
-268.75%
-847.45%
-380.37%
-21.47%
-95.28%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Mar 2024 is -46.28% vs 7.43% in Dec 2023

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Mar 2024 is 66.64% vs -215.74% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Mar 2024 is 12.18% vs -81.52% in Dec 2023

stock-summary

Interest

QoQ Growth in quarter ended Mar 2024 is -66.67% vs 0.00% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Mar 2024 has fallen from Dec 2023

Compare Quarterly Results Of Cue Health, Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
10.05
1.01
9.04
895.05%
Other Operating Income
0.00
0.00
0.00
Total Operating income
10.05
1.01
9.04
895.05%
Raw Material Cost
16.32
0.53
15.79
2,979.25%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.15
0.00
0.15
Selling and Distribution Expenses
8.50
3.18
5.32
167.30%
Other Expenses
2.91
0.02
2.89
14,450.00%
Total Expenditure (Excl Depreciation)
54.09
3.87
50.22
1,297.67%
Operating Profit (PBDIT) excl Other Income
-44.04
-2.86
-41.18
-1,439.86%
Other Income
0.81
0.00
0.81
Operating Profit (PBDIT)
-43.22
-2.71
-40.51
-1,494.83%
Interest
0.15
0.00
0.15
Exceptional Items
-6.14
-0.87
-5.27
-605.75%
Gross Profit (PBDT)
-6.26
0.49
-6.75
-1,377.55%
Depreciation
0.00
0.15
-0.15
-100.00%
Profit Before Tax
-49.52
-3.73
-45.79
-1,227.61%
Tax
0.00
0.00
0.00
Provisions and contingencies
0
0
0.00
Profit After Tax
-49.52
-3.73
-45.79
-1,227.61%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
-49.52
-3.73
-45.79
-1,227.61%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-49.52
-3.73
-45.79
-1,227.61%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
199.46
11.76
187.70
1,596.09%
Earnings per share (EPS)
-0.31
-0.08
-0.23
-287.50%
Diluted Earnings per share
-0.31
-0.08
-0.23
-287.50%
Operating Profit Margin (Excl OI)
-438.01%
-282.21%
0.00
-155.80%
Gross Profit Margin
-492.50%
-353.46%
0.00
-139.04%
PAT Margin
-492.50%
-368.28%
0.00
-124.22%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 1.01 Million
in Mar 2024

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2024 is -46.28% vs 7.43% in Dec 2023

stock-summary

YoY Growth in quarter ended Mar 2024 is -59.27% vs -86.18% in Mar 2023

Quarterly - Consolidate Net Profit
Consolidate Net Profit -4.95 Million
in Mar 2024

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2024 is 66.64% vs -215.74% in Dec 2023

stock-summary

YoY Growth in quarter ended Mar 2024 is 47.45% vs -3,464.29% in Mar 2023

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) -4.40 Million
in Mar 2024

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2024 is 12.18% vs -81.52% in Dec 2023

stock-summary

YoY Growth in quarter ended Mar 2024 is 40.14% vs -577.27% in Mar 2023

Quarterly - Interest
Interest 0.01 Million
in Mar 2024

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2024 is -66.67% vs 0.00% in Dec 2023

stock-summary

YoY Growth in quarter ended Mar 2024 is -50.00% vs 100.00% in Mar 2023

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -438.01%
in Mar 2024

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2024 has fallen from Dec 2023

stock-summary

YoY Growth in quarter ended Mar 2024 has fallen from Mar 2023